Dietary recommendations for obese patients with chronic kidney disease

被引:2
作者
Anderson, Cheryl A. M.
Miller, Edgar R., III
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] NIA, Baltimore, MD 21224 USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
关键词
diet; nutrition; CKD; obesity;
D O I
10.1053/j.ackd.2006.07.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
For optimal management of chronic kidney disease (CKD), dietary modification should be an integral part of patient care. Dietary considerations for obese patients with CKD are numerous and complicated and involve modification of intake of calories, protein, fat, phosphorus, and electrolytes. General principles for dietary management of obese patients include (1) ensuring adequate monitoring of nutritional status through assessment of diet, nutrition-related laboratory parameters, and anthropometrics; (2) creation of an individualized diet plan that meets clinical guidelines and has favorable effects on obesity-related conditions such as blood pressure and lipids; (3) careful attention to patients' food choices, portion size, and food-prepa ration methods; (4) recommending adjustment of overall energy intake to promote weight loss, yet maintain good nutritional status; and (5) modification of diet as the patient's nutritional status changes and CKD progresses. The basic objectives of dietary modification are to lighten the excretory load of products of metabolism and to help the kidney maintain normal equilibrium of the body's internal environment. Dietary modifications must be individualized and appropriate to the stage of CKD. This review describes dietary factors important in optimizing nutritional status of obese patients with CKD. Additionally, current clinical practice guidelines and strategies for meeting them are discussed. (c) 2006 by the National Kidney Foundation, Inc.
引用
收藏
页码:394 / 402
页数:9
相关论文
共 24 条
[1]   Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease:: A meta-analysis of randomized, controlled trials [J].
Alonso, A ;
Lau, J ;
Jaber, BL ;
Weintraub, A ;
Sarnak, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (01) :1-9
[2]  
[Anonymous], 1982, CIRCULATION, DOI DOI 10.1161/01.CIR.65.5.839
[3]   A clinical trial of the effects of dietary patterns on blood pressure [J].
Appel, LJ ;
Moore, TJ ;
Obarzanek, E ;
Vollmer, WM ;
Svetkey, LP ;
Sacks, FM ;
Bray, GA ;
Vogt, TM ;
Cutler, JA ;
Windhauser, MM ;
Lin, PH ;
Karanja, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (16) :1117-1124
[4]   Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids - Results of the OmniHeart randomized trial [J].
Appel, LJ ;
Sacks, FM ;
Carey, VJ ;
Obarzanek, E ;
Swain, JF ;
Miller, ER ;
Conlin, PR ;
Erlinger, TP ;
Rosner, BA ;
Laranjo, NM ;
Charleston, J ;
McCarron, P ;
Bishop, LM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (19) :2455-2464
[5]   BODY-WEIGHT AND MORTALITY [J].
BYERS, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (11) :723-724
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]  
Cowley AW, 1997, AM J CLIN NUTR, V65, P587
[8]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[9]   Effect of lipid reduction on the progression of renal disease: A meta-analysis [J].
Fried, LF ;
Orchard, TJ ;
Kasiske, BL .
KIDNEY INTERNATIONAL, 2001, 59 (01) :260-269
[10]   High urine volume and low urine osmolality are risk factors for faster progression of renal disease [J].
Hebert, LA ;
Greene, T ;
Levey, A ;
Falkenhain, ME ;
Klahr, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (05) :962-971